articleNature MedicineJan 1, 2002Closed access

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy

The University of Osaka · Fujita Health University

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

718
total citations
FWCI
36.75
Percentile
100%
References
24
Citations per year

Authors

18

Topics & keywords

Keywords
  • Epidermal growth factor
  • Transactivation
  • Muscle hypertrophy
  • Heparin-binding EGF-like growth factor
  • Metalloproteinase
  • Internal medicine
  • Endocrinology
  • Disintegrin
No related works found for this paper.